Tenax Therapeutics, Inc. Gains 22.96%
Tenax Therapeutics, Inc. (TENX:NASDAQ) soared at $0.57, representing a gain of 23%. The stock got featured on our News Catalysts scanner on Fri, Feb 17, 2023 at 07:31 AM in the 'MISCELLANEOUS' category. From Fri, Feb 24, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Thu, Feb 02, 2023 at $4.3 with a volume of 29M+.
About Tenax Therapeutics, Inc. (TENX:NASDAQ)
Tenax Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing & commercializing pharmaceutical products for critical care patients and its products include Levosimendan & Oxycyte.
Top 10 Gainers:
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 54.2%
- Cazoo Group Ltd Class A (CZOO:NYSE), 32.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 30.1%
- SportsMap Tech Acquisition Corp. (SMAP:NASDAQ), 29.83%
- Boxed Inc. (BOXD:NYSE), 26.89%
- Cingulate Inc. (CING:NASDAQ), 25%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 23.29%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 22.96%
- Solo Brands Inc. Class A (DTC:NYSE), 21.19%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 20.93%